Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin-Converting Enzyme Inhibitors: The Prospective EARLY Registry

  • Roland E. Schmieder, Sebastian A. Potthoff, Peter Bramlage, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Taoufik Ouarrak, Martina Ehmen, Jochen Senges, Anselm K. Gitt
  • Journal of Clinical Hypertension, June 2015, Wiley
  • DOI: 10.1111/jch.12603

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage